nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM2—Signaling Pathways—ITGB3—melanoma	0.000145	0.000145	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PRKCA—melanoma	0.000145	0.000145	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAP2K1—melanoma	0.000145	0.000145	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SPP1—melanoma	0.000144	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CD—melanoma	0.000144	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—FGF2—melanoma	0.000144	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAP2K2—melanoma	0.000144	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SPP1—melanoma	0.000144	0.000144	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—melanoma	0.000143	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAP2K2—melanoma	0.000143	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—melanoma	0.000143	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—PIK3CA—melanoma	0.000142	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SPP1—melanoma	0.000142	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAP2K2—melanoma	0.000142	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—melanoma	0.000142	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—KRAS—melanoma	0.000141	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—FGF2—melanoma	0.000138	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CG—melanoma	0.000137	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL2—melanoma	0.000137	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL2—melanoma	0.000137	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TERT—melanoma	0.000137	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—RAC1—melanoma	0.000136	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TERT—melanoma	0.000136	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—RAC1—melanoma	0.000136	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL2—melanoma	0.000135	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PIK3CA—melanoma	0.000135	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TERT—melanoma	0.000135	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—RAC1—melanoma	0.000134	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MDM2—melanoma	0.000134	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—ERBB2—melanoma	0.000132	0.000132	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARG—melanoma	0.000132	0.000132	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CB—melanoma	0.000131	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HIF1A—melanoma	0.000131	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HIF1A—melanoma	0.00013	0.00013	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PIK3CA—melanoma	0.000129	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HIF1A—melanoma	0.000129	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MDM2—melanoma	0.000129	0.000129	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—ERBB2—melanoma	0.000127	0.000127	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—melanoma	0.000126	0.000126	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CB—melanoma	0.000125	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KDR—melanoma	0.000125	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRAS—melanoma	0.000125	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KDR—melanoma	0.000125	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KDR—melanoma	0.000123	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1B—melanoma	0.000123	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AKT1—melanoma	0.000121	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CD—melanoma	0.000121	0.000121	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—melanoma	0.00012	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CASP3—melanoma	0.00012	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FN1—melanoma	0.00012	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL2—melanoma	0.00012	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FN1—melanoma	0.00012	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRAS—melanoma	0.00012	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—IL6—melanoma	0.000119	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—ALB—melanoma	0.000119	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FN1—melanoma	0.000119	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOTCH1—melanoma	0.000118	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1B—melanoma	0.000118	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOTCH1—melanoma	0.000117	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCND1—melanoma	0.000117	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AKT1—melanoma	0.000116	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOTCH1—melanoma	0.000116	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CTNNB1—melanoma	0.000116	0.000116	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CD80—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CASP3—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KIT—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APC—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CG—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—NRAS—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL2—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CD80—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KIT—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APC—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CG—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—NRAS—melanoma	0.000115	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—IL6—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CD80—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGF—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CG—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KIT—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APC—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—NRAS—melanoma	0.000114	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGF—melanoma	0.000113	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CDKN1A—melanoma	0.000113	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTEN—melanoma	0.000113	0.000113	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NFKB1—melanoma	0.000112	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGF—melanoma	0.000112	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCND1—melanoma	0.000112	0.000112	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CTNNB1—melanoma	0.000111	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AKT1—melanoma	0.00011	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK3—melanoma	0.00011	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK3—melanoma	0.00011	0.00011	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—melanoma	0.000109	0.000109	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK3—melanoma	0.000109	0.000109	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CDKN1A—melanoma	0.000108	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTEN—melanoma	0.000108	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—BRAF—melanoma	0.000108	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—BRAF—melanoma	0.000108	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NFKB1—melanoma	0.000108	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—BRAF—melanoma	0.000107	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AKT1—melanoma	0.000106	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IGF1—melanoma	0.000105	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CB—melanoma	0.000105	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IGF1—melanoma	0.000105	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—MAPK1—melanoma	0.000105	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—melanoma	0.000105	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—MAPK1—melanoma	0.000105	0.000105	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—melanoma	0.000104	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—melanoma	0.000104	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IGF1—melanoma	0.000104	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—MAPK1—melanoma	0.000103	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—melanoma	0.000103	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—melanoma	0.000102	0.000102	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAP2K1—melanoma	0.000102	0.000102	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAP2K1—melanoma	0.000101	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CD—melanoma	0.000101	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STAT3—melanoma	0.000101	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CD—melanoma	0.000101	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NRAS—melanoma	0.000101	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAP2K1—melanoma	0.000101	0.000101	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	0.0001	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	9.99e-05	9.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CD—melanoma	9.98e-05	9.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—KRAS—melanoma	9.9e-05	9.9e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	9.89e-05	9.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—KRAS—melanoma	9.87e-05	9.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—KRAS—melanoma	9.78e-05	9.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—melanoma	9.77e-05	9.77e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—FGF2—melanoma	9.68e-05	9.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STAT3—melanoma	9.68e-05	9.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—FGF2—melanoma	9.65e-05	9.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK3—melanoma	9.65e-05	9.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NRAS—melanoma	9.65e-05	9.65e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—FGF2—melanoma	9.56e-05	9.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MYC—melanoma	9.39e-05	9.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK3—melanoma	9.24e-05	9.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MAPK1—melanoma	9.19e-05	9.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—melanoma	9.18e-05	9.18e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CA—melanoma	9.1e-05	9.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTEN—melanoma	9.08e-05	9.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CA—melanoma	9.07e-05	9.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MDM2—melanoma	9.06e-05	9.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MDM2—melanoma	9.03e-05	9.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MYC—melanoma	8.99e-05	8.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CA—melanoma	8.98e-05	8.98e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MDM2—melanoma	8.94e-05	8.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—ERBB2—melanoma	8.93e-05	8.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—ERBB2—melanoma	8.91e-05	8.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—ERBB2—melanoma	8.82e-05	8.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CB—melanoma	8.82e-05	8.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MAPK1—melanoma	8.8e-05	8.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—melanoma	8.79e-05	8.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CB—melanoma	8.79e-05	8.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CB—melanoma	8.7e-05	8.7e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KRAS—melanoma	8.68e-05	8.68e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—melanoma	8.47e-05	8.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—melanoma	8.45e-05	8.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRAS—melanoma	8.42e-05	8.42e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRAS—melanoma	8.39e-05	8.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—melanoma	8.36e-05	8.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRAS—melanoma	8.31e-05	8.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KRAS—melanoma	8.31e-05	8.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1B—melanoma	8.27e-05	8.27e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1B—melanoma	8.25e-05	8.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AKT1—melanoma	8.18e-05	8.18e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1B—melanoma	8.17e-05	8.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AKT1—melanoma	8.16e-05	8.16e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CASP3—melanoma	8.11e-05	8.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL2—melanoma	8.1e-05	8.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CASP3—melanoma	8.08e-05	8.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AKT1—melanoma	8.08e-05	8.08e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL2—melanoma	8.07e-05	8.07e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—IL6—melanoma	8.06e-05	8.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—IL6—melanoma	8.03e-05	8.03e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CASP3—melanoma	8e-05	8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL2—melanoma	7.99e-05	7.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CA—melanoma	7.97e-05	7.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—IL6—melanoma	7.95e-05	7.95e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCND1—melanoma	7.89e-05	7.89e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCND1—melanoma	7.87e-05	7.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CTNNB1—melanoma	7.82e-05	7.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCND1—melanoma	7.79e-05	7.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CTNNB1—melanoma	7.79e-05	7.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CTNNB1—melanoma	7.72e-05	7.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—melanoma	7.71e-05	7.71e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—melanoma	7.66e-05	7.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—melanoma	7.64e-05	7.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CDKN1A—melanoma	7.64e-05	7.64e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CA—melanoma	7.63e-05	7.63e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTEN—melanoma	7.62e-05	7.62e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CDKN1A—melanoma	7.61e-05	7.61e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTEN—melanoma	7.59e-05	7.59e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NFKB1—melanoma	7.58e-05	7.58e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—melanoma	7.56e-05	7.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NFKB1—melanoma	7.56e-05	7.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CDKN1A—melanoma	7.54e-05	7.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTEN—melanoma	7.52e-05	7.52e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NFKB1—melanoma	7.48e-05	7.48e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AKT1—melanoma	7.43e-05	7.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AKT1—melanoma	7.41e-05	7.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—melanoma	7.38e-05	7.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRAS—melanoma	7.37e-05	7.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AKT1—melanoma	7.34e-05	7.34e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRAS—melanoma	7.06e-05	7.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—IL6—melanoma	7.06e-05	7.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—melanoma	6.88e-05	6.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—melanoma	6.86e-05	6.86e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STAT3—melanoma	6.81e-05	6.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NRAS—melanoma	6.8e-05	6.8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—melanoma	6.79e-05	6.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STAT3—melanoma	6.79e-05	6.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NRAS—melanoma	6.78e-05	6.78e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—IL6—melanoma	6.76e-05	6.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STAT3—melanoma	6.73e-05	6.73e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NRAS—melanoma	6.71e-05	6.71e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AKT1—melanoma	6.51e-05	6.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK3—melanoma	6.51e-05	6.51e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK3—melanoma	6.49e-05	6.49e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK3—melanoma	6.43e-05	6.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CA—melanoma	6.41e-05	6.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MYC—melanoma	6.33e-05	6.33e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MYC—melanoma	6.31e-05	6.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MYC—melanoma	6.25e-05	6.25e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT1—melanoma	6.24e-05	6.24e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MAPK1—melanoma	6.19e-05	6.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—melanoma	6.19e-05	6.19e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MAPK1—melanoma	6.17e-05	6.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—melanoma	6.17e-05	6.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MAPK1—melanoma	6.11e-05	6.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—melanoma	6.11e-05	6.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KRAS—melanoma	5.85e-05	5.85e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KRAS—melanoma	5.83e-05	5.83e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KRAS—melanoma	5.77e-05	5.77e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CA—melanoma	5.37e-05	5.37e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CA—melanoma	5.36e-05	5.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CA—melanoma	5.31e-05	5.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AKT1—melanoma	5.23e-05	5.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—melanoma	5.2e-05	5.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—melanoma	5.18e-05	5.18e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—melanoma	5.13e-05	5.13e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRAS—melanoma	4.97e-05	4.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRAS—melanoma	4.96e-05	4.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRAS—melanoma	4.91e-05	4.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—IL6—melanoma	4.76e-05	4.76e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—IL6—melanoma	4.74e-05	4.74e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—IL6—melanoma	4.7e-05	4.7e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT1—melanoma	4.39e-05	4.39e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT1—melanoma	4.38e-05	4.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT1—melanoma	4.33e-05	4.33e-05	CbGpPWpGaD
